NCT05014828 2025-08-24To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid TumorsBeiGenePhase 2 Completed58 enrolled 16 charts
NCT03477175 2025-01-07Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib TrialsEisai Inc.Phase 2 Completed40 enrolled 13 charts
NCT01433991 2021-06-08A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)Eisai Inc.Phase 1/2 Terminated30 enrolled 42 charts